Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 31.78 % |
3 Month Return | + 37.19 % |
1 Year Return | + 45.07 % |
Market Stats | |
Previous Close | ₹130.10 |
Open | ₹132.70 |
Volume | 51.70K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹149.43Cr |
P/E Ratio | 14.25 |
PEG Ratio | -356.15 |
Market Cap | ₹149.43 Cr |
P/B Ratio | 3.09 |
EPS | 7.52 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 4.77 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹149.43 Cr | 78.84% | 0.53 | ₹8 Cr | ₹167 Cr | |
BUY | ₹4,215.47 Cr | 7.77% | 0.63 | ₹94 Cr | ₹1,081 Cr | |
NA | ₹521.96 Cr | 32.07% | 0.51 | NA | NA | |
BUY | ₹11,736.94 Cr | 316.22% | 0.50 | ₹314 Cr | ₹2,177 Cr | |
NA | ₹326.38 Cr | 145.42% | 0.66 | ₹5 Cr | ₹155 Cr |
Organisation | Parnax Lab Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Parnax Lab Ltd
Parnax Lab's consolidated net sales for June 2024 reached Rs 50.12 crore, up 2.83% YoY. Net profit rose 19.82% to Rs 3.98 crore, with EBITDA increasing 29.53%. The EPS improved to Rs 3.47. Shares closed at Rs 113.30, yielding 32.19% returns over six months.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 4 quarters, 1.87 Cr → 3.98 Cr (in ₹), with an average increase of 20.2% per quarter
Price Rise
In the last 1 month, Parnax Lab stock has moved up by 31.8%
Revenue Rich
Revenue is up for the last 2 quarters, 46.62 Cr → 50.23 Cr (in ₹), with an average increase of 7.2% per quarter
Best in 3 Years
In the last 3 years, Parnax Lab has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 27.70% of holdings in Jun 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 72.30% of holdings in Jun 2024 quarter
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 80.6% return, outperforming this stock by 35.6%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 72.3% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 27.7% | 0.00 | |
Others | 0% | 0.00 |
Parnax Lab Ltd in the last 5 years
Lowest (-82.38x)
May 26, 2021
Today (14.25x)
September 6, 2024
Industry (59.14x)
September 6, 2024
Highest (177.62x)
February 9, 2021
Parnax Lab Ltd’s net profit jumped 19.88% since last year same period to ₹3.98Cr in the Q1 2024-2025. On a quarterly growth basis, Parnax Lab Ltd has generated 77.68% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Parnax Lab Ltd is currently in a Bullish trading position according to technical analysis indicators.
Parnax Lab Ltd (506128) share price today is ₹127.5
Parnax Lab Ltd is not listed on NSE
Parnax Lab Ltd is listed on BSE
PE Ratio of Parnax Lab Ltd is 14.25
PE ratio = Parnax Lab Ltd Market price per share / Parnax Lab Ltd Earnings per share
Today’s traded volume of Parnax Lab Ltd(506128) is 51.70K.
Today’s market capitalisation of Parnax Lab Ltd(506128) is ₹149.43Cr.
Parnax Lab Ltd(506128 | Price |
---|---|
52 Week High | ₹167.9 |
52 Week Low | ₹75.6 |
Parnax Lab Ltd(506128) share price is ₹127.5. It is down -24.06% from its 52 Week High price of ₹167.9
Parnax Lab Ltd(506128) share price is ₹127.5. It is up 68.65% from its 52 Week Low price of ₹75.6
Parnax Lab Ltd(506128 | Returns |
---|---|
1 Day Returns | -2.6% |
1 Month Returns | 31.78% |
3 Month Returns | 37.19% |
1 Year Returns | 45.07% |